Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer, Merck begin triple-drug immuno-oncology study
Pfizer, Merck begin triple-drug immuno-oncology study
Pfizer, Merck begin triple-drug immuno-oncology study
Submitted by
admin
on May 11, 2016 - 10:43am
Source:
BioPharma Dive
News Tags:
Pfizer
Merck
immuno-oncology
avelumab
Headline:
Pfizer, Merck begin triple-drug immuno-oncology study
Do Not Allow Advertisers to Use My Personal information
